Biovalys hosted two symposium sessions.

Biovalys hosted two symposium sessions.

Symposium 1 was honored by Assoc. (Honor). Prof. Tawee Chotpitayasunondh, M.D., who provided an epidemiology update on Streptococcus pneumoniae and shared clinical updates on the 13-valent pneumococcal conjugate vaccine (PCV13-TT).

Symposium 2 was honored by Assoc. (Honor). Prof. Tawee Chotpitayasunondh, M.D. and Assoc. Prof. Chonnamet Techasaensiri, M.D., who updated the audience on the epidemiology of Enterovirus 71 (EV71) and delivered valuable clinical insights on the EV71 vaccine and Chromatographically Purified Vero Cell Rabies Vaccine (CPRV), with a special focus on pre-exposure prophylaxis.

CPRV induces a strong immune response, for both intramuscular and intradermal administration.

PCV13-TT offers strong effectiveness and an affordable, accessible price.

The EV71 vaccine provides 97.3% protection against hand, foot and mouth disease caused by EV71.